{{'Search' | translate}}
 

Imidazole

Company: Fisher Scientific
Catalog#: O3196-500
Bio-protocol()
Company-protocol()
Other protocol()

Karyopherin-β2 Inhibits and Reverses Aggregation and Liquid-liquid Phase Separation of the ALS/FTD-Associated Protein FUS
Author:
Date:
2020-08-20
[Abstract]  The study of RNA-binding proteins (RBP) offers insight into the mechanisms of pathologic protein aggregation in neurodegenerative diseases. We developed a protocol for purifying an RBP FUS and a nuclear import receptor (NIR) Kapβ2 and testing the ability of Kapβ2 to mitigate FUS aggregation and liquid-liquid phase separation. [摘要]  [摘要] RNA结合蛋白的研究(RBP)报价洞察病理蛋白聚集的神经变性疾病的机制。我们开发了用于纯化RBP FUS和核输入受体(NIR)Kapβ2 的协议,并测试Kapβ2 减轻FUS聚集和液-液相分离的能力。

[背景] 肌萎缩性脊髓侧索硬化症(ALS)和额颞叶痴呆(FTD)是神经变性疾病,其特征在于所述错误定位几个RNA结合蛋白的和聚集(RBP)(麦肯齐等人,2010;达克鲁斯和克利夫兰,2011; King 等,2012)。其中一种蛋白是FUS(融合在肉瘤中),一种核蛋白在ALS / FTD患者的神经元细胞质中定位不正确,然后经历液-液相转变,然后发生异常的相转变,形成不溶性聚集体(Altmeyer 等, 2015; Burke 等人,2015; Lin 等人,2015; Molliex 等人,2015; Murakami 等人,2015; Patel 等人,2015)(图1)。Karyopherin-β2(甲β2),一个核输入受体(NIR),已经建立了作为伴侣和disaggregase 蛋白与PY-核定位序列(NLS),诸如FUS(过等人,2018; Hofweber 等人。,2018;吉泽,等人。,2018)。以下方案被开发,以测试的能力甲β2抑制和反向FUS聚合和相分离的离体(过等人,2018)。

D:\ ...

In vitro Measurement of CMP-Sialic Acid Transporter Activity in Reconstituted Proteoliposomes
Author:
Date:
2020-03-20
[Abstract]  Nucleotide-sugar transporters (NSTs) facilitate eukaryotic cellular glycosylation by transporting nucleotide-sugar conjugates into the Golgi lumen and endoplasmic reticulum for use by glycosyltransferases, while also transferring nucleotide monophosphate byproducts to the cytoplasm. Mutations in this family of proteins can cause a number of significant cellular pathologies, and wild type members can act as virulence factors for many parasites and fungi. Here, we describe an in vitro assay to measure the transport activity of the CMP-sialic acid transporter (CST), one of seven NSTs found in mammals. While in vitro transport assays have been previously described for CST, these studies failed to account for the fact that 1) commercially available stocks of CMP-sialic acid ... [摘要]  [ 摘要] 核苷酸糖转运蛋白(NST)通过将核苷酸糖结合物转运到高尔基腔和内质网供糖基转移酶使用,同时将核苷酸单磷酸副产物转移到细胞质中,从而促进了真核细胞的糖基化。该蛋白质家族的突变可引起许多重要的细胞病理,野生型成员可充当许多寄生虫和真菌的致病因子。在这里,我们描述了一种体外测定法,以测量CMP-唾液酸转运蛋白(CST)的转运活性,CMP-唾液酸转运蛋白(CST)是在哺乳动物中发现的七个NST之一。虽然在体外 以前已经针对CST进行了转运分析,但这些研究未能说明以下事实:1 )CMP- 唾液酸(CMP-Sia )的商业库存由约10%的高亲和力CMP组成,以及2)CMP- SIA 是水解d 到CMP和在水溶液中的唾液酸。在这里,我们描述了一种用非选择性磷酸酶南极磷酸酶治疗CMP-Sia的方法,以将所有游离CMP转化为胞苷。这使我们能够准确地测量重组为蛋白脂质体的纯化CST的底物亲和力和运输动力学。

[ 背景技术]一旦在细胞质或细胞核合成,核苷酸偶联的糖被输送到内质网的内腔(ER)由核苷酸-糖转运蛋白(NSTS)或高尔基体(青木等人,2003)。在这些亚细胞区室中,糖基转移酶利用糖部分糖基化脂质和蛋白质,产生副产物核苷酸单磷酸酯(NMP)(Capasso和Hirschberg,1984 ;Milla和Hirschberg ,1989; ...

Comments